As of Aug 26
| -0.29 / -0.79%|
The 2 analysts offering 12-month price forecasts for Medifast Inc have a median target of 37.50, with a high estimate of 39.00 and a low estimate of 36.00. The median estimate represents a +2.91% increase from the last price of 36.44.
The current consensus among 2 polled investment analysts is to Buy stock in Medifast Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.